After Pfizer, Novartis, and Sanofi, GlaxoSmithKline (GSK) was listed as the fourth pharmaceutical company in the world. Some other pharmaceutical companies merged to form GSK in 2000. Following this, the business started its search for new drugs and antibiotics. GSK’s primary goal is to combat illness by combining human talent, technology, and knowledge. This company intends to improve the health of 2.5 million people worldwide by the year 2030. Adorateb works with GSK to supply Iran’s health centers with the most recent GSK-produced medications and vaccines.
GlaxoSmithKline
GSK
Adorateb is the distributor of GSK products in Iran, contact for more information
A summary of GSK’s previous activities
GSK is a multinational company whose main office is located in England. Two pharmaceutical companies, Glaxo Wellcome and SmithKline Beecham, merged to form the company in 2000. Forbes ranked GSK as the sixth-largest pharmaceutical company globally in 2019. This company has made significant efforts to create and develop a variety of medications and vaccines that have changed global health. Among its pharmaceutical products are amoxicillin, zidovudine, mercaptopurine, and pyrimethamine—a few of the essential drugs listed by the World Health Organization. With four worldwide centers for research and development, GSK hopes to enhance the state of world health by the year 2030.
Products and areas of expertise of the GlaxoSmithKline Company
In recent years, the GSK research and development team has focused on drug resistance and the decline in antibiotic efficacy. Alongside this research and efforts to address this important issue, GSK is also actively pursuing pharmaceutical innovations in the areas of oncology, autoimmune diseases, respiratory diseases, HIV, and infectious diseases. This company manufactures a range of medications and vaccines, including COVID vaccine, as well as dental health products under the brands Sensodyne, Boost, Horlicks, and Javizken.